Electrochemical Formation and Characterization of Functional Ag-Re Coatings. [PDF]
Bersirova O +3 more
europepmc +1 more source
Introduction Rheumatoid sarcopenia, characterized by the progressive loss of skeletal muscle mass and function, is a frequent comorbidity in rheumatoid arthritis (RA), linked to prolonged, severe systemic inflammation. Purinergic signaling (adenosine, AMP, and ATP) plays a crucial role in inflammation, myogenesis, and muscle hypertrophy.
Miguel Marco‐Bonilla +13 more
wiley +1 more source
Liposomal <sup>188</sup>Rhenium Plus Macrophage Depletion Enhances Anti-PD-L1 Efficacy and B Cell Infiltration Against Lung Metastatic Cancer. [PDF]
Liu SY, Lin LT, Chang CH, Chen YJ.
europepmc +1 more source
Objective To evaluate the timeline for resolution of sacroiliac joint (SIJ) inflammation, changes in structural lesions, and their correlation with patient‐reported outcomes in youth with axial juvenile spondyloarthritis (axJSpA) initiating TNF inhibitor (TNFi).
Timothy G. Brandon +8 more
wiley +1 more source
Caffeic Acid-Driven Green Synthesis of Rhenium Nanoparticles Embedded in Self-Templating Double-Shelled ZnMn2O4 Hollow Microspheres for Ultrasensitive Epinephrine Detection in Biofluids. [PDF]
Sakthivel R +8 more
europepmc +1 more source
Dysregulation of U12‐Type Splicing in Lupus Neutrophils
Abstract. Objective Neutrophil dysfunction is a hallmark of systemic lupus erythematosus (SLE), but its molecular basis remains unclear. This study explores transcriptional and post‐transcriptional changes in low‐density granulocytes (LDGs), a proinflammatory neutrophil subset expanded in SLE, focusing on NADPH oxidase (Nox) function and minor intron ...
Luz P. Blanco +11 more
wiley +1 more source
Machine Learning-Guided Design of Rhenium Tricarbonyl Complexes for Next-Generation Antibiotics. [PDF]
Nedyalkova M +11 more
europepmc +1 more source
Enhancing Stability of Cu/ZnO Catalysts in the CO<sub>2</sub> Hydrogenation to Methanol by the Addition of MoO<sub>3</sub> and ReO<sub>3</sub> Promoters. [PDF]
Soriano Rodríguez J +5 more
europepmc +1 more source
Objectives Lupus nephritis (LN) is one of the most severe manifestations of systemic lupus erythematosus (SLE) and is partially driven by type I interferon (IFN) signaling. Anifrolumab, an approved treatment for patients with SLE, has been investigated in a phase 2 trial in patients with LN receiving standard therapy (TULIP‐LN, NCT02547922). We studied
Andrea Fava +8 more
wiley +1 more source
Efficacy, Safety, and Patient Reported Outcomes of Rhenium-Skin Cancer Therapy for Non-Melanoma Skin Cancer: 1-Year Results from the EPIC-Skin Study. [PDF]
Cardaci G +11 more
europepmc +1 more source

